Annual Operating Profit
-$9.52 M
+$10.86 M+53.30%
31 December 2023
Summary:
Ampio Pharmaceuticals annual operaing income is currently -$9.52 million, with the most recent change of +$10.86 million (+53.30%) on 31 December 2023. During the last 3 years, it has risen by +$6.32 million (+39.89%). AMPE annual operating profit is now -951700.00% below its all-time high of -$1000.00, reached on 31 December 2006.AMPE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$2.21 M
-$815.00 K-58.21%
31 December 2023
Summary:
Ampio Pharmaceuticals quarterly operating income is currently -$2.21 million, with the most recent change of -$815.00 thousand (-58.21%) on 31 December 2023. Over the past year, it has dropped by -$815.00 thousand (-58.21%). AMPE quarterly operating profit is now -738233.33% below its all-time high of -$300.00, reached on 30 September 2006.AMPE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$9.52 M
+$486.00 K+4.86%
31 December 2023
Summary:
Ampio Pharmaceuticals TTM operating income is currently -$9.52 million, with the most recent change of +$486.00 thousand (+4.86%) on 31 December 2023. Over the past year, it has increased by +$486.00 thousand (+4.86%). AMPE TTM operating profit is now -3172566.67% below its all-time high of -$300.00, reached on 30 September 2006.AMPE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPE Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.3% | -58.2% | +4.9% |
| 3 y3 years | +39.9% | +42.5% | +37.6% |
| 5 y5 years | +14.9% | +57.2% | +31.9% |
AMPE Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +53.7% | -58.2% | +76.0% | at high | +64.6% |
| 5 y | 5 years | at high | +53.7% | -58.2% | +76.0% | at high | +64.6% |
| alltime | all time | <-9999.0% | +69.7% | <-9999.0% | +78.9% | <-9999.0% | +73.9% |
Ampio Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$9.52 M(-53.3%) | -$2.21 M(+58.2%) | -$9.52 M(-4.9%) |
| Sept 2023 | - | -$1.40 M(-10.3%) | -$10.00 M(-30.2%) |
| June 2023 | - | -$1.56 M(-64.1%) | -$14.33 M(-19.3%) |
| Mar 2023 | - | -$4.34 M(+60.8%) | -$17.75 M(-12.9%) |
| Dec 2022 | -$20.38 M(-0.9%) | -$2.70 M(-52.8%) | -$20.38 M(-24.3%) |
| Sept 2022 | - | -$5.72 M(+14.7%) | -$26.90 M(+7.5%) |
| June 2022 | - | -$4.99 M(-28.4%) | -$25.03 M(+5.5%) |
| Mar 2022 | - | -$6.96 M(-24.5%) | -$23.72 M(+15.3%) |
| Dec 2021 | -$20.57 M(+29.9%) | -$9.23 M(+139.6%) | -$20.57 M(+34.9%) |
| Sept 2021 | - | -$3.85 M(+4.8%) | -$15.25 M(+3.7%) |
| June 2021 | - | -$3.67 M(-3.8%) | -$14.71 M(+7.9%) |
| Mar 2021 | - | -$3.82 M(-2.4%) | -$13.63 M(-13.9%) |
| Dec 2020 | -$15.83 M(-14.8%) | -$3.91 M(+18.4%) | -$15.83 M(-17.0%) |
| Sept 2020 | - | -$3.30 M(+27.0%) | -$19.07 M(-8.9%) |
| June 2020 | - | -$2.60 M(-56.8%) | -$20.94 M(-4.5%) |
| Mar 2020 | - | -$6.02 M(-15.7%) | -$21.92 M(+18.0%) |
| Dec 2019 | -$18.58 M(+66.1%) | -$7.15 M(+38.1%) | -$18.58 M(+33.0%) |
| Sept 2019 | - | -$5.17 M(+44.5%) | -$13.97 M(+30.1%) |
| June 2019 | - | -$3.58 M(+33.8%) | -$10.73 M(+4.4%) |
| Mar 2019 | - | -$2.68 M(+5.5%) | -$10.29 M(-8.0%) |
| Dec 2018 | -$11.18 M(-28.7%) | -$2.54 M(+30.8%) | -$11.18 M(-16.9%) |
| Sept 2018 | - | -$1.94 M(-38.0%) | -$13.46 M(-8.0%) |
| June 2018 | - | -$3.13 M(-12.4%) | -$14.63 M(-9.6%) |
| Mar 2018 | - | -$3.57 M(-25.7%) | -$16.18 M(+3.7%) |
| Dec 2017 | -$15.68 M(-8.2%) | -$4.81 M(+55.0%) | -$15.61 M(+13.6%) |
| Sept 2017 | - | -$3.11 M(-33.8%) | -$13.75 M(-1.7%) |
| June 2017 | - | -$4.69 M(+56.2%) | -$13.99 M(+2.4%) |
| Mar 2017 | - | -$3.00 M(+1.9%) | -$13.66 M(-20.0%) |
| Dec 2016 | -$17.08 M(-29.3%) | -$2.95 M(-11.8%) | -$17.08 M(-20.3%) |
| Sept 2016 | - | -$3.34 M(-23.4%) | -$21.43 M(-8.4%) |
| June 2016 | - | -$4.37 M(-32.0%) | -$23.39 M(-5.7%) |
| Mar 2016 | - | -$6.42 M(-12.0%) | -$24.80 M(+2.6%) |
| Dec 2015 | -$24.17 M | -$7.29 M(+37.6%) | -$24.17 M(+24.5%) |
| Sept 2015 | - | -$5.30 M(-8.3%) | -$19.41 M(-17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | -$5.78 M(-0.2%) | -$23.60 M(-11.8%) |
| Mar 2015 | - | -$5.79 M(+128.6%) | -$26.77 M(-14.9%) |
| Dec 2014 | -$31.45 M(+30.9%) | -$2.53 M(-73.3%) | -$31.45 M(-13.7%) |
| Sept 2014 | - | -$9.50 M(+6.2%) | -$36.45 M(+10.8%) |
| June 2014 | - | -$8.94 M(-14.7%) | -$32.90 M(+8.2%) |
| Mar 2014 | - | -$10.48 M(+39.0%) | -$30.41 M(+26.6%) |
| Dec 2013 | -$24.02 M(+103.2%) | -$7.54 M(+26.8%) | -$24.02 M(+18.7%) |
| Sept 2013 | - | -$5.94 M(-8.0%) | -$20.24 M(+18.4%) |
| June 2013 | - | -$6.46 M(+58.0%) | -$17.10 M(+32.5%) |
| Mar 2013 | - | -$4.09 M(+8.8%) | -$12.91 M(+9.2%) |
| Dec 2012 | -$11.82 M(+6.2%) | -$3.76 M(+34.1%) | -$11.82 M(-6.3%) |
| Sept 2012 | - | -$2.80 M(+23.6%) | -$12.61 M(+0.2%) |
| June 2012 | - | -$2.27 M(-24.4%) | -$12.58 M(+5.8%) |
| Mar 2012 | - | -$3.00 M(-34.1%) | -$11.89 M(+6.8%) |
| Dec 2011 | -$11.13 M(+66.1%) | -$4.55 M(+64.3%) | -$11.13 M(+35.2%) |
| Sept 2011 | - | -$2.77 M(+75.7%) | -$8.23 M(+4.3%) |
| June 2011 | - | -$1.58 M(-29.5%) | -$7.90 M(+5.8%) |
| Mar 2011 | - | -$2.24 M(+35.7%) | -$7.46 M(+11.3%) |
| Dec 2010 | -$6.70 M(+343.5%) | -$1.65 M(-32.2%) | -$6.70 M(+18.8%) |
| Sept 2010 | - | -$2.43 M(+112.7%) | -$5.64 M(+51.5%) |
| June 2010 | - | -$1.14 M(-22.7%) | -$3.73 M(+24.6%) |
| Mar 2010 | - | -$1.48 M(+151.3%) | -$2.99 M(+97.8%) |
| Dec 2009 | -$1.51 M(+5076.4%) | -$588.60 K(+14.2%) | -$1.51 M(+63.0%) |
| Sept 2009 | - | -$515.20 K(+26.4%) | -$927.10 K(+121.6%) |
| June 2009 | - | -$407.70 K(+9607.1%) | -$418.30 K(+1327.6%) |
| Dec 2008 | -$29.20 K(-6.4%) | -$4200.00(-34.4%) | -$29.30 K(-12.8%) |
| Sept 2008 | - | -$6400.00(+137.0%) | -$33.60 K(-2.6%) |
| June 2008 | - | -$2700.00(-83.1%) | -$34.50 K(-26.4%) |
| Mar 2008 | - | -$16.00 K(+88.2%) | -$46.90 K(+50.3%) |
| Dec 2007 | -$31.20 K(+3020.0%) | -$8500.00(+16.4%) | -$31.20 K(+35.7%) |
| Sept 2007 | - | -$7300.00(-51.7%) | -$23.00 K(+43.8%) |
| June 2007 | - | -$15.10 K(+4933.3%) | -$16.00 K(+1677.8%) |
| Mar 2007 | - | -$300.00(0.0%) | -$900.00(+50.0%) |
| Dec 2006 | -$1000.00 | -$300.00(0.0%) | -$600.00(+100.0%) |
| Sept 2006 | - | -$300.00 | -$300.00 |
FAQ
- What is Ampio Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual operating profit year-on-year change?
- What is Ampio Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly operating profit year-on-year change?
- What is Ampio Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM operating profit year-on-year change?
What is Ampio Pharmaceuticals annual operaing income?
The current annual operating profit of AMPE is -$9.52 M
What is the all time high annual operating profit for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual operaing income is -$1000.00
What is Ampio Pharmaceuticals annual operating profit year-on-year change?
Over the past year, AMPE annual operaing income has changed by +$10.86 M (+53.30%)
What is Ampio Pharmaceuticals quarterly operating income?
The current quarterly operating profit of AMPE is -$2.21 M
What is the all time high quarterly operating profit for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly operating income is -$300.00
What is Ampio Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, AMPE quarterly operating income has changed by -$815.00 K (-58.21%)
What is Ampio Pharmaceuticals TTM operating income?
The current TTM operating profit of AMPE is -$9.52 M
What is the all time high TTM operating profit for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM operating income is -$300.00
What is Ampio Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, AMPE TTM operating income has changed by +$486.00 K (+4.86%)